Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
- 2020
English
0009-7322
10.1161/CIRCULATIONAHA.119.044703 [doi] NIHMS1591512 [mid] PMC7301778 [pmc]
*Adrenal Cortex Hormones/ad [Administration & Dosage]
*Adrenal Cortex Hormones/ae [Adverse Effects]
*Immune Checkpoint Inhibitors/ad [Administration & Dosage]
*Immune Checkpoint Inhibitors/ae [Adverse Effects]
*Myocarditis/ci [Chemically Induced]
*Myocarditis/di [Diagnosis]
Cardiovascular Diseases/ci [Chemically Induced]
Cardiovascular Diseases/di [Diagnosis]
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Registries
Retrospective Studies
MedStar Heart & Vascular Institute
Letter
English
0009-7322
10.1161/CIRCULATIONAHA.119.044703 [doi] NIHMS1591512 [mid] PMC7301778 [pmc]
*Adrenal Cortex Hormones/ad [Administration & Dosage]
*Adrenal Cortex Hormones/ae [Adverse Effects]
*Immune Checkpoint Inhibitors/ad [Administration & Dosage]
*Immune Checkpoint Inhibitors/ae [Adverse Effects]
*Myocarditis/ci [Chemically Induced]
*Myocarditis/di [Diagnosis]
Cardiovascular Diseases/ci [Chemically Induced]
Cardiovascular Diseases/di [Diagnosis]
Dose-Response Relationship, Drug
Drug Administration Schedule
Humans
Registries
Retrospective Studies
MedStar Heart & Vascular Institute
Letter